nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclopentolate—BCHE—Irinotecan—lung cancer	0.364	0.551	CbGbCtD
Cyclopentolate—BCHE—Cisplatin—lung cancer	0.297	0.449	CbGbCtD
Cyclopentolate—Eye redness—Gefitinib—lung cancer	0.0309	0.132	CcSEcCtD
Cyclopentolate—BCHE—diaphragm—lung cancer	0.0196	0.575	CbGeAlD
Cyclopentolate—Ocular hyperaemia—Gefitinib—lung cancer	0.0149	0.0637	CcSEcCtD
Cyclopentolate—Lacrimation increased—Pemetrexed—lung cancer	0.00765	0.0326	CcSEcCtD
Cyclopentolate—Photophobia—Crizotinib—lung cancer	0.00724	0.0309	CcSEcCtD
Cyclopentolate—Hyperpyrexia—Paclitaxel—lung cancer	0.00654	0.0279	CcSEcCtD
Cyclopentolate—Lacrimation—Irinotecan—lung cancer	0.00508	0.0217	CcSEcCtD
Cyclopentolate—Vasodilation—Vinorelbine—lung cancer	0.00412	0.0176	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Vinorelbine—lung cancer	0.00412	0.0176	CcSEcCtD
Cyclopentolate—Photophobia—Vinblastine—lung cancer	0.00409	0.0175	CcSEcCtD
Cyclopentolate—Conjunctivitis—Pemetrexed—lung cancer	0.00383	0.0164	CcSEcCtD
Cyclopentolate—Conjunctivitis—Gefitinib—lung cancer	0.00381	0.0163	CcSEcCtD
Cyclopentolate—Lacrimation—Docetaxel—lung cancer	0.00351	0.015	CcSEcCtD
Cyclopentolate—Vasodilation—Irinotecan—lung cancer	0.0034	0.0145	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Irinotecan—lung cancer	0.0034	0.0145	CcSEcCtD
Cyclopentolate—Lacrimation increased—Irinotecan—lung cancer	0.00324	0.0138	CcSEcCtD
Cyclopentolate—Vision blurred—Crizotinib—lung cancer	0.00318	0.0136	CcSEcCtD
Cyclopentolate—Venlafaxine—ABCG2—lung cancer	0.00271	0.537	CrCbGaD
Cyclopentolate—Flushing—Teniposide—lung cancer	0.00266	0.0114	CcSEcCtD
Cyclopentolate—Lacrimation increased—Paclitaxel—lung cancer	0.00264	0.0113	CcSEcCtD
Cyclopentolate—Dry mouth—Gefitinib—lung cancer	0.00255	0.0109	CcSEcCtD
Cyclopentolate—Agitation—Teniposide—lung cancer	0.00229	0.00979	CcSEcCtD
Cyclopentolate—Conjunctivitis—Erlotinib—lung cancer	0.00228	0.00972	CcSEcCtD
Cyclopentolate—CHRM1—trachea—lung cancer	0.00227	0.0664	CbGeAlD
Cyclopentolate—Lacrimation increased—Docetaxel—lung cancer	0.00224	0.00956	CcSEcCtD
Cyclopentolate—BCHE—respiratory system—lung cancer	0.00224	0.0657	CbGeAlD
Cyclopentolate—Lacrimation—Doxorubicin—lung cancer	0.00219	0.00935	CcSEcCtD
Cyclopentolate—Paralysis—Methotrexate—lung cancer	0.00214	0.00914	CcSEcCtD
Cyclopentolate—Tachycardia—Teniposide—lung cancer	0.00199	0.00848	CcSEcCtD
Cyclopentolate—Abdominal distension—Irinotecan—lung cancer	0.00189	0.00805	CcSEcCtD
Cyclopentolate—Paralysis—Doxorubicin—lung cancer	0.00185	0.00791	CcSEcCtD
Cyclopentolate—BCHE—bronchus—lung cancer	0.00184	0.054	CbGeAlD
Cyclopentolate—Pruritus—Pemetrexed—lung cancer	0.00178	0.00759	CcSEcCtD
Cyclopentolate—Pruritus—Gefitinib—lung cancer	0.00177	0.00754	CcSEcCtD
Cyclopentolate—Rash—Crizotinib—lung cancer	0.00174	0.0074	CcSEcCtD
Cyclopentolate—Dermatitis—Crizotinib—lung cancer	0.00173	0.0074	CcSEcCtD
Cyclopentolate—Vertigo—Vinblastine—lung cancer	0.00171	0.0073	CcSEcCtD
Cyclopentolate—Flushing—Vinorelbine—lung cancer	0.00169	0.0072	CcSEcCtD
Cyclopentolate—Ataxia—Paclitaxel—lung cancer	0.00166	0.00709	CcSEcCtD
Cyclopentolate—BCHE—trachea—lung cancer	0.00166	0.0485	CbGeAlD
Cyclopentolate—Convulsion—Vinblastine—lung cancer	0.00165	0.00704	CcSEcCtD
Cyclopentolate—CHRM1—lung—lung cancer	0.00163	0.0477	CbGeAlD
Cyclopentolate—Rash—Pemetrexed—lung cancer	0.00159	0.00677	CcSEcCtD
Cyclopentolate—Dermatitis—Pemetrexed—lung cancer	0.00158	0.00676	CcSEcCtD
Cyclopentolate—Rash—Gefitinib—lung cancer	0.00158	0.00672	CcSEcCtD
Cyclopentolate—Dermatitis—Gefitinib—lung cancer	0.00157	0.00672	CcSEcCtD
Cyclopentolate—BCHE—cardiac atrium—lung cancer	0.00155	0.0456	CbGeAlD
Cyclopentolate—Abdominal distension—Paclitaxel—lung cancer	0.00154	0.00656	CcSEcCtD
Cyclopentolate—Conjunctivitis—Cisplatin—lung cancer	0.00147	0.00629	CcSEcCtD
Cyclopentolate—Vasodilation—Doxorubicin—lung cancer	0.00147	0.00626	CcSEcCtD
Cyclopentolate—Vasodilation procedure—Doxorubicin—lung cancer	0.00147	0.00626	CcSEcCtD
Cyclopentolate—Pruritus—Teniposide—lung cancer	0.00144	0.00615	CcSEcCtD
Cyclopentolate—Vertigo—Vinorelbine—lung cancer	0.00142	0.00607	CcSEcCtD
Cyclopentolate—Ataxia—Docetaxel—lung cancer	0.00141	0.00601	CcSEcCtD
Cyclopentolate—Lacrimation increased—Doxorubicin—lung cancer	0.0014	0.00596	CcSEcCtD
Cyclopentolate—Flushing—Irinotecan—lung cancer	0.00139	0.00594	CcSEcCtD
Cyclopentolate—Coma—Methotrexate—lung cancer	0.00136	0.0058	CcSEcCtD
Cyclopentolate—Conjunctivitis—Paclitaxel—lung cancer	0.00132	0.00565	CcSEcCtD
Cyclopentolate—BCHE—bone marrow—lung cancer	0.00131	0.0385	CbGeAlD
Cyclopentolate—Coordination abnormal—Doxorubicin—lung cancer	0.00131	0.0056	CcSEcCtD
Cyclopentolate—Rash—Teniposide—lung cancer	0.00128	0.00548	CcSEcCtD
Cyclopentolate—Dermatitis—Teniposide—lung cancer	0.00128	0.00548	CcSEcCtD
Cyclopentolate—Flushing—Cisplatin—lung cancer	0.00126	0.00539	CcSEcCtD
Cyclopentolate—Tachycardia—Vinorelbine—lung cancer	0.00126	0.00538	CcSEcCtD
Cyclopentolate—BCHE—lung—lung cancer	0.00119	0.0349	CbGeAlD
Cyclopentolate—Coma—Doxorubicin—lung cancer	0.00118	0.00502	CcSEcCtD
Cyclopentolate—Vertigo—Irinotecan—lung cancer	0.00117	0.005	CcSEcCtD
Cyclopentolate—Flushing—Etoposide—lung cancer	0.00116	0.00494	CcSEcCtD
Cyclopentolate—Flushing—Paclitaxel—lung cancer	0.00113	0.00484	CcSEcCtD
Cyclopentolate—Venlafaxine—ABCB1—lung cancer	0.00113	0.224	CrCbGaD
Cyclopentolate—Conjunctivitis—Docetaxel—lung cancer	0.00112	0.00479	CcSEcCtD
Cyclopentolate—Vision blurred—Cisplatin—lung cancer	0.00112	0.00477	CcSEcCtD
Cyclopentolate—Tremor—Cisplatin—lung cancer	0.00111	0.00474	CcSEcCtD
Cyclopentolate—Pruritus—Topotecan—lung cancer	0.00107	0.00456	CcSEcCtD
Cyclopentolate—Pruritus—Erlotinib—lung cancer	0.00106	0.00451	CcSEcCtD
Cyclopentolate—Convulsion—Cisplatin—lung cancer	0.00103	0.00438	CcSEcCtD
Cyclopentolate—Ataxia—Methotrexate—lung cancer	0.00102	0.00433	CcSEcCtD
Cyclopentolate—Vision blurred—Paclitaxel—lung cancer	0.001	0.00428	CcSEcCtD
Cyclopentolate—Tremor—Paclitaxel—lung cancer	0.000997	0.00426	CcSEcCtD
Cyclopentolate—Agitation—Paclitaxel—lung cancer	0.000978	0.00417	CcSEcCtD
Cyclopentolate—Vertigo—Etoposide—lung cancer	0.000975	0.00416	CcSEcCtD
Cyclopentolate—Flushing—Docetaxel—lung cancer	0.000962	0.0041	CcSEcCtD
Cyclopentolate—Vertigo—Paclitaxel—lung cancer	0.000956	0.00408	CcSEcCtD
Cyclopentolate—Rash—Topotecan—lung cancer	0.000952	0.00406	CcSEcCtD
Cyclopentolate—Dermatitis—Topotecan—lung cancer	0.000951	0.00406	CcSEcCtD
Cyclopentolate—Somnolence—Irinotecan—lung cancer	0.000947	0.00404	CcSEcCtD
Cyclopentolate—Tachycardia—Cisplatin—lung cancer	0.000944	0.00403	CcSEcCtD
Cyclopentolate—Rash—Erlotinib—lung cancer	0.000942	0.00402	CcSEcCtD
Cyclopentolate—Dermatitis—Erlotinib—lung cancer	0.000941	0.00402	CcSEcCtD
Cyclopentolate—Convulsion—Etoposide—lung cancer	0.000941	0.00401	CcSEcCtD
Cyclopentolate—Somnolence—Gemcitabine—lung cancer	0.000923	0.00394	CcSEcCtD
Cyclopentolate—Convulsion—Paclitaxel—lung cancer	0.000922	0.00394	CcSEcCtD
Cyclopentolate—Pruritus—Vinorelbine—lung cancer	0.000914	0.0039	CcSEcCtD
Cyclopentolate—Dry mouth—Paclitaxel—lung cancer	0.000886	0.00378	CcSEcCtD
Cyclopentolate—Ataxia—Doxorubicin—lung cancer	0.000879	0.00375	CcSEcCtD
Cyclopentolate—Tachycardia—Etoposide—lung cancer	0.000865	0.00369	CcSEcCtD
Cyclopentolate—Tachycardia—Paclitaxel—lung cancer	0.000848	0.00362	CcSEcCtD
Cyclopentolate—Drowsiness—Methotrexate—lung cancer	0.000832	0.00355	CcSEcCtD
Cyclopentolate—Rash—Vinorelbine—lung cancer	0.000814	0.00348	CcSEcCtD
Cyclopentolate—Dermatitis—Vinorelbine—lung cancer	0.000814	0.00347	CcSEcCtD
Cyclopentolate—Abdominal distension—Doxorubicin—lung cancer	0.000814	0.00347	CcSEcCtD
Cyclopentolate—BCHE—lymph node—lung cancer	0.000813	0.0238	CbGeAlD
Cyclopentolate—Conjunctivitis—Methotrexate—lung cancer	0.000809	0.00345	CcSEcCtD
Cyclopentolate—Somnolence—Etoposide—lung cancer	0.000788	0.00336	CcSEcCtD
Cyclopentolate—Convulsion—Docetaxel—lung cancer	0.000782	0.00334	CcSEcCtD
Cyclopentolate—Somnolence—Paclitaxel—lung cancer	0.000772	0.0033	CcSEcCtD
Cyclopentolate—Dry mouth—Docetaxel—lung cancer	0.000751	0.00321	CcSEcCtD
Cyclopentolate—Pruritus—Gemcitabine—lung cancer	0.000734	0.00313	CcSEcCtD
Cyclopentolate—Drowsiness—Doxorubicin—lung cancer	0.000721	0.00307	CcSEcCtD
Cyclopentolate—Tachycardia—Docetaxel—lung cancer	0.000719	0.00307	CcSEcCtD
Cyclopentolate—Conjunctivitis—Doxorubicin—lung cancer	0.0007	0.00299	CcSEcCtD
Cyclopentolate—Rash—Irinotecan—lung cancer	0.000672	0.00287	CcSEcCtD
Cyclopentolate—Dermatitis—Irinotecan—lung cancer	0.000671	0.00286	CcSEcCtD
Cyclopentolate—Somnolence—Docetaxel—lung cancer	0.000655	0.00279	CcSEcCtD
Cyclopentolate—Rash—Gemcitabine—lung cancer	0.000654	0.00279	CcSEcCtD
Cyclopentolate—Dermatitis—Gemcitabine—lung cancer	0.000654	0.00279	CcSEcCtD
Cyclopentolate—Pruritus—Etoposide—lung cancer	0.000627	0.00267	CcSEcCtD
Cyclopentolate—Pruritus—Paclitaxel—lung cancer	0.000615	0.00262	CcSEcCtD
Cyclopentolate—Vision blurred—Methotrexate—lung cancer	0.000613	0.00262	CcSEcCtD
Cyclopentolate—Rash—Cisplatin—lung cancer	0.00061	0.0026	CcSEcCtD
Cyclopentolate—Dermatitis—Cisplatin—lung cancer	0.000609	0.0026	CcSEcCtD
Cyclopentolate—Pethidine—ALB—lung cancer	0.000604	0.12	CrCbGaD
Cyclopentolate—Flushing—Doxorubicin—lung cancer	0.0006	0.00256	CcSEcCtD
Cyclopentolate—Orphenadrine—CYP2E1—lung cancer	0.0006	0.119	CrCbGaD
Cyclopentolate—Vertigo—Methotrexate—lung cancer	0.000584	0.00249	CcSEcCtD
Cyclopentolate—Convulsion—Methotrexate—lung cancer	0.000563	0.0024	CcSEcCtD
Cyclopentolate—Rash—Etoposide—lung cancer	0.000559	0.00238	CcSEcCtD
Cyclopentolate—Dermatitis—Etoposide—lung cancer	0.000558	0.00238	CcSEcCtD
Cyclopentolate—Rash—Paclitaxel—lung cancer	0.000548	0.00234	CcSEcCtD
Cyclopentolate—Dermatitis—Paclitaxel—lung cancer	0.000547	0.00234	CcSEcCtD
Cyclopentolate—Vision blurred—Doxorubicin—lung cancer	0.000531	0.00226	CcSEcCtD
Cyclopentolate—Pruritus—Docetaxel—lung cancer	0.000521	0.00222	CcSEcCtD
Cyclopentolate—Agitation—Doxorubicin—lung cancer	0.000518	0.00221	CcSEcCtD
Cyclopentolate—Vertigo—Doxorubicin—lung cancer	0.000506	0.00216	CcSEcCtD
Cyclopentolate—Convulsion—Doxorubicin—lung cancer	0.000488	0.00208	CcSEcCtD
Cyclopentolate—Somnolence—Methotrexate—lung cancer	0.000472	0.00201	CcSEcCtD
Cyclopentolate—Dry mouth—Doxorubicin—lung cancer	0.000469	0.002	CcSEcCtD
Cyclopentolate—Rash—Docetaxel—lung cancer	0.000464	0.00198	CcSEcCtD
Cyclopentolate—Dermatitis—Docetaxel—lung cancer	0.000464	0.00198	CcSEcCtD
Cyclopentolate—Tachycardia—Doxorubicin—lung cancer	0.000449	0.00191	CcSEcCtD
Cyclopentolate—Somnolence—Doxorubicin—lung cancer	0.000409	0.00174	CcSEcCtD
Cyclopentolate—Pruritus—Methotrexate—lung cancer	0.000376	0.0016	CcSEcCtD
Cyclopentolate—Rash—Methotrexate—lung cancer	0.000335	0.00143	CcSEcCtD
Cyclopentolate—Dermatitis—Methotrexate—lung cancer	0.000334	0.00143	CcSEcCtD
Cyclopentolate—Pruritus—Doxorubicin—lung cancer	0.000325	0.00139	CcSEcCtD
Cyclopentolate—Rash—Doxorubicin—lung cancer	0.00029	0.00124	CcSEcCtD
Cyclopentolate—Dermatitis—Doxorubicin—lung cancer	0.00029	0.00124	CcSEcCtD
Cyclopentolate—CHRM1—Signaling Pathways—PXN—lung cancer	5.14e-05	0.000788	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PXN—lung cancer	5.13e-05	0.000786	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—AVP—lung cancer	5.09e-05	0.00078	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	5.09e-05	0.000779	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of proteins—MMP2—lung cancer	5.08e-05	0.000779	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—AVP—lung cancer	5.08e-05	0.000778	CbGpPWpGaD
Cyclopentolate—BCHE—Neuronal System—HRAS—lung cancer	5.07e-05	0.000777	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ABCG2—lung cancer	5.05e-05	0.000774	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ADCY1—lung cancer	5.05e-05	0.000774	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	5.04e-05	0.000772	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AKR1C1—lung cancer	5.04e-05	0.000772	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GRP—lung cancer	5.04e-05	0.000772	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—OXTR—lung cancer	5.04e-05	0.000772	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GRP—lung cancer	5.02e-05	0.000769	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AKR1C1—lung cancer	5.02e-05	0.000769	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—OXTR—lung cancer	5.02e-05	0.000769	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ENO2—lung cancer	4.96e-05	0.000759	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—HPGDS—lung cancer	4.96e-05	0.000759	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PPP2R1B—lung cancer	4.92e-05	0.000755	CbGpPWpGaD
Cyclopentolate—CHRM1—Circadian rythm related genes—IL6—lung cancer	4.87e-05	0.000746	CbGpPWpGaD
Cyclopentolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	4.82e-05	0.000739	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GSTT1—lung cancer	4.81e-05	0.000737	CbGpPWpGaD
Cyclopentolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—lung cancer	4.81e-05	0.000736	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GCLC—lung cancer	4.75e-05	0.000728	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CYP2A6—lung cancer	4.75e-05	0.000728	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—GNG11—lung cancer	4.71e-05	0.000722	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—GNG11—lung cancer	4.7e-05	0.00072	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—STK11—lung cancer	4.68e-05	0.000718	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR ligand binding—CXCL8—lung cancer	4.63e-05	0.00071	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—AVP—lung cancer	4.62e-05	0.000709	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR ligand binding—CXCL8—lung cancer	4.62e-05	0.000708	CbGpPWpGaD
Cyclopentolate—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	4.61e-05	0.000707	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—AVP—lung cancer	4.61e-05	0.000706	CbGpPWpGaD
Cyclopentolate—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—lung cancer	4.6e-05	0.000705	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ENO1—lung cancer	4.5e-05	0.00069	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—VEGFC—lung cancer	4.49e-05	0.000688	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—VEGFC—lung cancer	4.47e-05	0.000686	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—PTEN—lung cancer	4.39e-05	0.000674	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—GSTP1—lung cancer	4.33e-05	0.000664	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ADCY1—lung cancer	4.24e-05	0.00065	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ADCY1—lung cancer	4.22e-05	0.000648	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of proteins—CXCL8—lung cancer	4.22e-05	0.000647	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CAT—lung cancer	4.22e-05	0.000646	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—EP300—lung cancer	4.19e-05	0.000642	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PPP2R1B—lung cancer	4.13e-05	0.000633	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SMARCA4—lung cancer	4.13e-05	0.000633	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SMARCA4—lung cancer	4.12e-05	0.000631	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PPP2R1B—lung cancer	4.12e-05	0.000631	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—ABCB1—lung cancer	4.1e-05	0.000628	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CYP2E1—lung cancer	4.04e-05	0.000619	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—TYMS—lung cancer	4.03e-05	0.000617	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—NQO1—lung cancer	3.99e-05	0.000612	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HSPB1—lung cancer	3.99e-05	0.000611	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—GSTM1—lung cancer	3.98e-05	0.00061	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HSPB1—lung cancer	3.97e-05	0.000609	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PTHLH—lung cancer	3.94e-05	0.000604	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PTHLH—lung cancer	3.93e-05	0.000602	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CYP1A1—lung cancer	3.77e-05	0.000578	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—ERCC2—lung cancer	3.74e-05	0.000574	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ANXA1—lung cancer	3.7e-05	0.000568	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ANXA1—lung cancer	3.69e-05	0.000566	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—STK11—lung cancer	3.6e-05	0.000552	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FLT1—lung cancer	3.59e-05	0.00055	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FLT1—lung cancer	3.58e-05	0.000548	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—PIK3CG—lung cancer	3.55e-05	0.000545	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—PIK3CG—lung cancer	3.54e-05	0.000543	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—APP—lung cancer	3.51e-05	0.000538	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NOTCH3—lung cancer	3.51e-05	0.000538	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—APP—lung cancer	3.5e-05	0.000537	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NOTCH3—lung cancer	3.5e-05	0.000537	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FGF9—lung cancer	3.48e-05	0.000534	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FGF9—lung cancer	3.47e-05	0.000532	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—POMC—lung cancer	3.38e-05	0.000519	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—POMC—lung cancer	3.37e-05	0.000517	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GSTP1—lung cancer	3.33e-05	0.000511	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—JUNB—lung cancer	3.33e-05	0.00051	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—JUNB—lung cancer	3.32e-05	0.000508	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CAT—lung cancer	3.24e-05	0.000497	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—APOA1—lung cancer	3.24e-05	0.000496	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PIK3CG—lung cancer	3.23e-05	0.000495	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PIK3CG—lung cancer	3.22e-05	0.000493	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ABCB1—lung cancer	3.15e-05	0.000483	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—PIK3CD—lung cancer	3.12e-05	0.000479	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—PIK3CD—lung cancer	3.11e-05	0.000477	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	3.1e-05	0.000475	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—TYMS—lung cancer	3.1e-05	0.000475	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—POMC—lung cancer	3.07e-05	0.000471	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—POMC—lung cancer	3.06e-05	0.000469	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—GSTM1—lung cancer	3.06e-05	0.000469	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—STK11—lung cancer	3.02e-05	0.000463	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—STK11—lung cancer	3.01e-05	0.000461	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—IL6R—lung cancer	3e-05	0.000459	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—IL6R—lung cancer	2.99e-05	0.000458	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PIK3CG—lung cancer	2.96e-05	0.000453	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FOXO3—lung cancer	2.91e-05	0.000447	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FOXO3—lung cancer	2.91e-05	0.000445	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CYP1A1—lung cancer	2.9e-05	0.000445	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ERCC2—lung cancer	2.88e-05	0.000441	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—MAP2K1—lung cancer	2.86e-05	0.000438	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—MAP2K1—lung cancer	2.85e-05	0.000436	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PIK3CD—lung cancer	2.84e-05	0.000435	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PIK3CD—lung cancer	2.83e-05	0.000433	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—POMC—lung cancer	2.81e-05	0.000431	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—CREBBP—lung cancer	2.74e-05	0.00042	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AVP—lung cancer	2.73e-05	0.000419	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—PIK3CB—lung cancer	2.72e-05	0.000417	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AVP—lung cancer	2.72e-05	0.000417	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—PIK3CB—lung cancer	2.71e-05	0.000416	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IGF1R—lung cancer	2.63e-05	0.000403	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IGF1R—lung cancer	2.62e-05	0.000402	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—CXCL8—lung cancer	2.62e-05	0.000401	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—CXCL8—lung cancer	2.61e-05	0.0004	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PIK3CD—lung cancer	2.6e-05	0.000398	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HES1—lung cancer	2.58e-05	0.000396	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HES1—lung cancer	2.57e-05	0.000395	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—ALB—lung cancer	2.57e-05	0.000393	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—RAF1—lung cancer	2.53e-05	0.000388	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—RAF1—lung cancer	2.53e-05	0.000387	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—IL2—lung cancer	2.5e-05	0.000383	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—IL2—lung cancer	2.49e-05	0.000382	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—APOA1—lung cancer	2.49e-05	0.000382	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PIK3CB—lung cancer	2.47e-05	0.000379	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PIK3CB—lung cancer	2.47e-05	0.000378	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—CXCL8—lung cancer	2.38e-05	0.000364	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—CXCL8—lung cancer	2.37e-05	0.000363	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ERBB3—lung cancer	2.36e-05	0.000362	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ERBB3—lung cancer	2.35e-05	0.000361	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PIK3CG—lung cancer	2.27e-05	0.000348	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—IL2—lung cancer	2.27e-05	0.000348	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PIK3CB—lung cancer	2.27e-05	0.000347	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—IL2—lung cancer	2.26e-05	0.000347	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TERT—lung cancer	2.26e-05	0.000347	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TERT—lung cancer	2.26e-05	0.000346	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PTGS2—lung cancer	2.24e-05	0.000344	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—FGFR1—lung cancer	2.2e-05	0.000337	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—FGFR1—lung cancer	2.19e-05	0.000336	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HIF1A—lung cancer	2.16e-05	0.000332	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—POMC—lung cancer	2.16e-05	0.000332	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HIF1A—lung cancer	2.16e-05	0.000331	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—CREBBP—lung cancer	2.11e-05	0.000323	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—APOA1—lung cancer	2.09e-05	0.00032	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—APOA1—lung cancer	2.08e-05	0.000319	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—KDR—lung cancer	2.07e-05	0.000317	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—KDR—lung cancer	2.06e-05	0.000316	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PIK3CD—lung cancer	2e-05	0.000306	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—ALB—lung cancer	1.97e-05	0.000302	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PTEN—lung cancer	1.96e-05	0.0003	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—KIT—lung cancer	1.91e-05	0.000292	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PIK3CG—lung cancer	1.91e-05	0.000292	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—APC—lung cancer	1.91e-05	0.000292	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—NRAS—lung cancer	1.91e-05	0.000292	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—APC—lung cancer	1.9e-05	0.000291	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PIK3CG—lung cancer	1.9e-05	0.000291	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—KIT—lung cancer	1.9e-05	0.000291	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—NRAS—lung cancer	1.9e-05	0.000291	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—EGF—lung cancer	1.88e-05	0.000289	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—EGF—lung cancer	1.88e-05	0.000288	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—EP300—lung cancer	1.87e-05	0.000286	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—MAPK3—lung cancer	1.83e-05	0.00028	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—MAPK3—lung cancer	1.82e-05	0.000279	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—POMC—lung cancer	1.82e-05	0.000278	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—POMC—lung cancer	1.81e-05	0.000277	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—BRAF—lung cancer	1.79e-05	0.000275	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—BRAF—lung cancer	1.79e-05	0.000274	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IL6R—lung cancer	1.77e-05	0.000271	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CREBBP—lung cancer	1.77e-05	0.000271	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IL6R—lung cancer	1.76e-05	0.00027	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CREBBP—lung cancer	1.76e-05	0.00027	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PIK3CB—lung cancer	1.74e-05	0.000267	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—EGFR—lung cancer	1.74e-05	0.000266	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—EGFR—lung cancer	1.73e-05	0.000265	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PTGS2—lung cancer	1.73e-05	0.000264	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MAP2K1—lung cancer	1.69e-05	0.000259	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MAP2K1—lung cancer	1.68e-05	0.000258	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PIK3CD—lung cancer	1.68e-05	0.000257	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PIK3CD—lung cancer	1.67e-05	0.000256	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—PIK3CA—lung cancer	1.66e-05	0.000254	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—PIK3CA—lung cancer	1.66e-05	0.000254	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—KRAS—lung cancer	1.64e-05	0.000252	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—KRAS—lung cancer	1.64e-05	0.000251	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—PIK3CA—lung cancer	1.51e-05	0.000231	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PTEN—lung cancer	1.51e-05	0.000231	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—PIK3CA—lung cancer	1.5e-05	0.00023	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MDM2—lung cancer	1.5e-05	0.00023	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MDM2—lung cancer	1.5e-05	0.000229	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—RAF1—lung cancer	1.5e-05	0.000229	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—RAF1—lung cancer	1.49e-05	0.000229	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—ERBB2—lung cancer	1.48e-05	0.000227	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—ERBB2—lung cancer	1.48e-05	0.000226	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MTOR—lung cancer	1.46e-05	0.000224	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PIK3CB—lung cancer	1.46e-05	0.000224	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MTOR—lung cancer	1.46e-05	0.000223	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PIK3CB—lung cancer	1.46e-05	0.000223	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—EP300—lung cancer	1.44e-05	0.00022	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CXCL8—lung cancer	1.4e-05	0.000215	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CXCL8—lung cancer	1.4e-05	0.000214	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—HRAS—lung cancer	1.39e-05	0.000214	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—HRAS—lung cancer	1.39e-05	0.000213	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—PIK3CA—lung cancer	1.38e-05	0.000212	CbGpPWpGaD
Cyclopentolate—CHRM1—GPCR downstream signaling—AKT1—lung cancer	1.36e-05	0.000208	CbGpPWpGaD
Cyclopentolate—CHRM3—GPCR downstream signaling—AKT1—lung cancer	1.35e-05	0.000207	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CASP3—lung cancer	1.34e-05	0.000206	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IL2—lung cancer	1.34e-05	0.000206	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CASP3—lung cancer	1.34e-05	0.000205	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IL2—lung cancer	1.34e-05	0.000205	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—IL6—lung cancer	1.34e-05	0.000205	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—IL6—lung cancer	1.33e-05	0.000204	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CCND1—lung cancer	1.31e-05	0.0002	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—JUN—lung cancer	1.31e-05	0.0002	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CCND1—lung cancer	1.3e-05	0.0002	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—JUN—lung cancer	1.3e-05	0.000199	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MMP9—lung cancer	1.27e-05	0.000195	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MMP9—lung cancer	1.27e-05	0.000194	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—CDKN1A—lung cancer	1.27e-05	0.000194	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PTEN—lung cancer	1.26e-05	0.000193	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—CDKN1A—lung cancer	1.26e-05	0.000193	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PTEN—lung cancer	1.26e-05	0.000193	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling by GPCR—AKT1—lung cancer	1.23e-05	0.000189	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling by GPCR—AKT1—lung cancer	1.23e-05	0.000188	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—EP300—lung cancer	1.2e-05	0.000185	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—EP300—lung cancer	1.2e-05	0.000184	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—SRC—lung cancer	1.17e-05	0.000179	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—SRC—lung cancer	1.17e-05	0.000179	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—VEGFA—lung cancer	1.14e-05	0.000175	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—VEGFA—lung cancer	1.14e-05	0.000174	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—STAT3—lung cancer	1.13e-05	0.000173	CbGpPWpGaD
Cyclopentolate—BCHE—Metabolism—AKT1—lung cancer	1.13e-05	0.000173	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—NRAS—lung cancer	1.13e-05	0.000173	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—STAT3—lung cancer	1.13e-05	0.000172	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—NRAS—lung cancer	1.12e-05	0.000172	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MAPK3—lung cancer	1.08e-05	0.000165	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MAPK3—lung cancer	1.08e-05	0.000165	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—PIK3CA—lung cancer	1.06e-05	0.000163	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—MYC—lung cancer	1.05e-05	0.000161	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—MYC—lung cancer	1.05e-05	0.00016	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—EGFR—lung cancer	1.03e-05	0.000157	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—EGFR—lung cancer	1.02e-05	0.000157	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—KRAS—lung cancer	9.69e-06	0.000149	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—KRAS—lung cancer	9.66e-06	0.000148	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—PIK3CA—lung cancer	8.91e-06	0.000137	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—PIK3CA—lung cancer	8.88e-06	0.000136	CbGpPWpGaD
Cyclopentolate—CHRM3—Metabolism—AKT1—lung cancer	8.67e-06	0.000133	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—TP53—lung cancer	8.62e-06	0.000132	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—TP53—lung cancer	8.59e-06	0.000132	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—HRAS—lung cancer	8.24e-06	0.000126	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—HRAS—lung cancer	8.21e-06	0.000126	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—IL6—lung cancer	7.89e-06	0.000121	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—IL6—lung cancer	7.86e-06	0.00012	CbGpPWpGaD
Cyclopentolate—CHRM1—Signaling Pathways—AKT1—lung cancer	7.28e-06	0.000112	CbGpPWpGaD
Cyclopentolate—CHRM3—Signaling Pathways—AKT1—lung cancer	7.25e-06	0.000111	CbGpPWpGaD
